Title : Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.

Pub. Date : 2020 Jun

PMID : 32366905






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mechanistically, A-485 inhibited p300-mediated histone acetylation, leading to disruption of BRD4-NUT binding to hyperacetylated megadomains. A-485 NUT midline carcinoma family member 1 Homo sapiens